Table 2 Baseline characteristics
From: Molecular mutations as a possible factor for determining extent of thyroid surgery
Mutation | n | Mean age | Gender (F:M) | Mean final pathology size (cm) | Mean U/S size (cm) | FNA bethesda score distribution (%) | |||
|---|---|---|---|---|---|---|---|---|---|
VI | V | IV | III | ||||||
BRAF V600E | 32 | 46.53 | 1.21 | 1.70 | 1.8 | 87 | 13 | 0 | 0 |
BRAF K601E | 4 | 47.00 | 1.5 | 1.08* | 1.2 | 0 | 75 | 25 | 0 |
RAS | 18 | 45.83 | 1.33 | 2.38 | 2.4 | 28 | 33 | 11 | 28 |
TERT | 2 | 67.00 | 1 | 2.80* | 2.1 | 50 | 0 | 50 | 0 |
RET/PTC1 | 1 | 46.00 | 1 | 1.50 | 1.80 | 100 | 0 | 0 | 0 |
PAX8/PPARγ | 1 | 51.96 | 0 | 1.00 | 1.40 | 0 | 0 | 100 | 0 |
No mutations | 45 | 51.96 | 1.31 | 1.85 | 2.2 | 29 | 38 | 22 | 11 |